## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `tesamorelin-diabetic-neuropathy` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `tesamorelin-diabetic-neuropathy` v2 · content_hash `4eff26e8382247a1…` · thread_head genesis · 24 DIVs - **thesis (c1):** No completed human trials test tesamorelin specifically for diabetic neuropathy. - c2 [human/active] A 12-week human trial in type 2 diabetic patients found tesamorelin did not alter insulin response or glycemic control versus placebo. - c4 [human/active] Tesamorelin is associated with reports of paresthesia, hypoesthesia, and peripheral neuropathy in clinical data. - c3 [preclinical/active] Animal studies indicate growth hormone can accelerate peripheral nerve regeneration after injury. - c5 [anecdotal/active] Reddit users report numbness or carpal tunnel-like symptoms during tesamorelin use, sometimes resolving after discontinuation. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `tesamorelin-diabetic-neuropathy` - **title:** Tesamorelin for Diabetic Neuropathy: Evidence Review - **url:** https://miscsubjects.com/a/tesamorelin-diabetic-neuropathy - **register:** source_ledger - **updated:** 2026-07-17T02:42:21.877Z - **tags:** peptide, matrix ## Body ## What's breaking down if you have Diabetic neuropathy Diabetic neuropathy involves progressive nerve damage tied to long-term high blood sugar. Layers include axonal degeneration, myelin sheath breakdown, reduced blood flow to nerves, and impaired nerve repair signals. If your condition includes these, degeneration outpaces the body's natural repair processes. The focus here stays on pathways that might support repair rather than suppress symptoms like pain. ## Why Tesamorelin might help you 1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name. 2. **Therefore for you:** If the GH axis or visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain. Tesamorelin acts as a growth hormone-releasing hormone analog. It prompts the pituitary to release more growth hormone, which in turn raises IGF-1 levels. Growth hormone and IGF-1 have been linked in animal models to supporting axonal regeneration after nerve injury. If your neuropathy involves slowed nerve regrowth, this pathway could relate to repair mechanisms rather than symptom control. In a human study of type 2 diabetes patients, 12 weeks of tesamorelin did not worsen insulin response, fasting glucose, or HbA1c compared to placebo (human data). This matters if metabolic stability is a concern alongside neuropathy. No direct link to nerve repair in diabetic neuropathy appears in available records. ## How these fit together Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. - **Tesamorelin** → GH axis / visceral fat The discussion centers on one layer only: potential support for GH-mediated tissue repair signals. No stacking details apply here. ## What the evidence actually shows No completed human trials test tesamorelin specifically for diabetic neuropathy (human tier: absence of data). A planned clinical trial (NCT03150511) examines tesamorelin for recovery after traumatic peripheral nerve injury, not diabetic cases; results are not yet available (human tier: planned study). One 12-week human trial in type 2 diabetic patients found tesamorelin did not change glycemic control or insulin sensitivity versus placebo (human data, source s5). Animal studies show growth hormone can speed peripheral nerve regeneration and reduce muscle atrophy after injury (preclinical tier). FDA labels and trials report paresthesia, hypoesthesia, and peripheral neuropathy as adverse events in some patients (human tier). FAERS data links tesamorelin to higher reporting of carpal tunnel syndrome (human tier, source s18). ## What scientists say Researchers note growth hormone's role in nerve regeneration from animal work. The Johns Hopkins trial aims to test whether tesamorelin improves functional outcomes after nerve repair by boosting this pathway. Scientists highlight the need for human data specific to diabetic neuropathy, which remains absent. Metabolic studies in diabetics provide reassurance on short-term glucose stability but do not address neuropathy progression. ## What people say on Reddit Anecdotal reports mention side effects such as hand numbness or carpal tunnel-like symptoms during tesamorelin use; some users link these to the compound and note resolution after stopping (anecdotal tier). Discussions reference the peripheral nerve injury trial with interest in regeneration potential, but no personal accounts describe benefits for diabetic neuropathy (anecdotal tier). Posts about nerve pain often appear in unrelated contexts. ## What people say on X Limited public posts discuss tesamorelin in neuropathy contexts. Mentions focus on general GH benefits or trial awareness rather than personal diabetic neuropathy experiences (anecdotal tier, sparse). ## What we do not know Direct evidence on tesamorelin altering diabetic neuropathy progression, nerve conduction, or symptoms in humans is missing. Long-term effects on nerve repair in diabetic populations remain untested. Interactions with existing diabetic neuropathy treatments lack study data. Whether GH elevation translates to meaningful repair in chronic metabolic nerve damage versus acute injury stays speculative. ## Safety and limits Tesamorelin carries warnings for potential glucose intolerance and diabetes risk; monitoring is advised in diabetic patients (human data). It is contraindicated in active cancer or certain pituitary issues. Injection site reactions and fluid retention appear in trials. All claims here derive from available studies and labels; no compound guarantees repair or safety for any individual condition. Evidence grading separates clear human trial results from animal work and user reports. ## Claims (5) - **c2** [human w=0.8] A 12-week human trial in type 2 diabetic patients found tesamorelin did not alter insulin response or glycemic control versus placebo. - who_claims: grok/grok-4.3 - sources: s5 - **c1** [human w=0.8] No completed human trials test tesamorelin specifically for diabetic neuropathy. - who_claims: grok/grok-4.3 - sources: s0 - **c4** [human w=0.8] Tesamorelin is associated with reports of paresthesia, hypoesthesia, and peripheral neuropathy in clinical data. - who_claims: grok/grok-4.3 - sources: s7 - **c3** [preclinical w=0.5] Animal studies indicate growth hormone can accelerate peripheral nerve regeneration after injury. - who_claims: grok/grok-4.3 - sources: s1 - **c5** [anecdotal w=0.3] Reddit users report numbness or carpal tunnel-like symptoms during tesamorelin use, sometimes resolving after discontinuation. - who_claims: grok/grok-4.3 - sources: s29, s35 ## Voxel graph (5 atoms · 11 edges) - full graph: https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (6) - chain valid: yes · head: `9a9a58100494144d` ### s0 · clinical_trial · ok - title: Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury - url: https://clinicaltrials.gov/study/NCT03150511 - summary: Ongoing/planned trial for traumatic nerve injury, not diabetic neuropathy. - quote: The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. - claim_ids: c1 - hash: `8e0e6de4e112963b` ### s1 · other · ok - title: Tesamorelin Therapy for Peripheral Nerve Injury Proposal - url: https://www.foundationforpn.org/wp-content/uploads/2025/01/Tesamorelin-Therapy-to-Enhance-Axonal-Regeneration-Minimize-Muscle-Atrophy-and-Improve-Functional-Outcomes-Following-Peripheral-Nerve-Injury-and-Repair.pdf - summary: Background on preclinical GH nerve regeneration data. - quote: Many animal studies have shown that growth hormone, via its downstream factors, can speed peripheral nerve regeneration following injury - claim_ids: c3 - hash: `b83416e7e2f9df6f` ### s5 · pubmed · ok - title: Safety and metabolic effects of tesamorelin in type 2 diabetic patients - url: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179538 - summary: Human metabolic study in diabetics showing neutral effect on glucose control. - quote: Treatment of type 2 diabetic patients with tesamorelin for 12 weeks did not alter insulin response or glycemic control. - claim_ids: c2 - hash: `302b8b27b3f37df9` ### s7 · other · ok - title: EGRIFTA (tesamorelin) FDA Label - url: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022505s000lbl.pdf - summary: Adverse event data including nerve symptoms. - quote: Hypoesthesia 4.2% vs 1.5% placebo; Neuropathy peripheral listed in adverse reactions. - claim_ids: c4 - hash: `ed0fcbc7110d980f` ### s29 · reddit · ok - title: Tesamorelin - no recomp occurring - url: https://www.reddit.com/r/Peptides/comments/1e4ai7g/tesamorelin_no_recomp_occurring/ - summary: User mention of nerve pain medication alongside tesamorelin use. - quote: I had to go back up a lot on a medication for nerve pain called Lyrica - claim_ids: c5 - hash: `61139c36383c74cf` ### s35 · reddit · ok - title: Tesamorelin/ipamorelin side effects - url: https://www.reddit.com/r/Peptidesource/comments/1o3ffie/tesamorelinipamorelin_side_effects/ - summary: Anecdotal reports of numbness with tesamorelin. - quote: Has anyone had terrible numbness n hands using tesa?? - claim_ids: c5 - hash: `9a9a58100494144d` ## Provenance (2 model passes) - chain valid: yes · head: `617f427a9e57fb51` - write · grok/grok-4.3 · 2026-06-29T23:24 · hash `646f29e4ab0e` - voxel_divide · owner · 2026-07-17T02:42 · hash `617f427a9e57` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-diabetic-neuropathy","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-diabetic-neuropathy|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-diabetic-neuropathy|tier|assertion` - **iMessage ask:** `tesamorelin-diabetic-neuropathy|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `tesamorelin-diabetic-neuropathy` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-diabetic-neuropathy/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*